Trial intelligence / Profile preview

SMUP-IA-01 Long-term Follow-up in Knee Osteoarthritis

NCT06798727Phase 2Active, not recruiting

Sponsor
MEDIPOST
Start
Mar 2023
Primary completion
Mar 2027
Modality
Mesenchymal Stem Cells
Countries
1
01

Overview

A Phase 2 trial of SMUP-IA-01 in knee osteoarthritis (OA), sponsored by MEDIPOST. Started Mar 2023; status: active, not recruiting.

02

Drugs

SMUP-IA-01
03

Conditions

knee osteoarthritis (OA)

Beyond the preview

Go deeper on NCT06798727.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06798727.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call